Owlet, Inc. (OWLT) is a Lehi, Utah-based pediatric health company that sells connected infant-monitoring products — the FDA-cleared Dream Sock wearable, the Dream Sight camera and the Dream Duo bundle — alongside its Owlet360 subscription platform. Shares traded at $3.07 shortly after Monday's open, down 10.76% from Friday's close of $3.44, which was itself 25.54% below Thursday's $4.62. The direction is unambiguously lower. The immediate reason cited by markets is the ongoing fallout from a camera cable-guard safety notice, a retail stop-ship and a pulled 2026 outlook, reinforced Monday morning by a steep price-target cut.
The dominant driver remains Friday's disclosure. Alongside third-quarter results — revenue of $30.4 million, down 4.9% year over year but above consensus, adjusted earnings of $0.11 per share, gross margin of 53.8%, record adjusted EBITDA of $3.5 million and 142,000 paying subscribers — Owlet said a toddler died after becoming entangled in a loose, exposed camera cable and that it had logged 91 adhesive-related complaints about its cable guards.
The company is shipping a free enclosed replacement guard, issued a formal stop-ship across retail channels for Dream Sight and Dream Duo, and withdrew its 2026 revenue outlook of $118 million to $122 million. Management guided to a net fourth-quarter impact of $13 million to $18 million, including $7 million to $10 million of direct program costs and $9 million to $12 million of retailer returns, partly offset by recoverable inventory and possible insurance recovery of up to $10 million that is not guaranteed. The matter has been reported to regulators. Against a market capitalization near $90 million, that is a material hit to a business whose camera bundles sit in the holiday selling window.
The fresh catalyst on Monday was the first major analyst reset. TD Cowen cut its target to $4 from $10 while keeping a Buy rating, arguing shares will likely stay range bound until the safety issue is resolved and sales reaccelerate. The note called the disruption transitory, highlighted FDA-cleared Dream Sock demand and subscription momentum, and flagged brand-perception spillover and retail disruption as key risks. Even after the cut, the target sits above the current price — a signal of limited further downside in the analyst's view, but also a much lower valuation anchor than investors held last week.
Friday's session was not a straight-line decline: shares opened at $2.99, touched a 52-week low of $2.75, then closed at $3.44 — a 25% recovery from the low that reflected dip-buying and short covering. Monday's drop retraces roughly half of that bounce, a pattern consistent with sellers using the rebound to exit. The stock now trades well below both its 50-day and 200-day moving averages, keeping the trend firmly negative.
Friday's volume of about 2.26 million shares was roughly ten times the stock's average daily turnover near 211,000, confirming genuine institutional repositioning rather than retail noise. Monday's opening half hour was active but far lighter, with a pace above normal turnover yet nowhere near Friday's flush. The move was company-specific: broad indices opened lower on tech weakness, but no comparable declines appeared across healthcare equipment, and Owlet's roughly 15.8 million-share float means relatively small orders can move the tape. With the $2.75 low now the obvious line in the sand, the stock is trading in a thin, headline-driven range.
The score runs from 0, meaning no meaningful news and a move that is routine for the stock, to 100, meaning transformative news and an extreme, rare price move. Owlet scores 65 out of 100. The verified news is major for a company this size: a fatality-linked safety action, a retail stop-ship in the peak quarter, a $13 million to $18 million estimated hit and a withdrawn outlook, followed by a 60% price-target cut. The price move was about 3.4 times the stock's typical daily change, and only two sessions in the past 69 traded more sharply. Strong news and a moderately unusual move combine into the mid-60s.
Attention now shifts to the holiday quarter. Investors will look for evidence that retailers restock Dream Sight and Dream Duo with the new guards, that Dream Sock sell-through holds up, and that Owlet360 subscriber growth continues at its recent pace. The next earnings report is expected in early March 2027, and with formal guidance withdrawn, management commentary will carry more weight than usual. Also on the watch list: any additional regulatory steps, insurance recovery confirmation, litigation developments and estimate revisions from the remaining covering analysts. Risks are skewed toward demand damage and brand erosion; the offset is a core sock business that management says was tracking ahead of plan before the disruption.
Tickeron offers hundreds of AI trading bots covering thousands of tickers across multiple markets. Because performance varies widely by design, only the strongest performers under current market conditions appear in the curated Trending AI Robots section. Bots differ by strategy, timeframe, performance metrics and the symbols they trade, so the lineup rotates as conditions change. Reviewing the current leaders is a practical way to see which approaches are working in this tape — explore the page to compare the models in focus today.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
It is expected that a price bounce should occur soon.
Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where OWLT advanced for three days, in 209 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
OWLT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 52 cases where OWLT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.
The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OWLT as a result. In 71 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for OWLT turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 42 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OWLT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for OWLT entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.847) is normal, around the industry mean (4.142). P/E Ratio (-13.900) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.967) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. OWLT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OWLT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry MedicalNursingServices